The genome of a Serratia marcescens strain (C7) that was found in the pitcher fluids of a Sarracenia rosea pitcher plant was sequenced using the Illumina platform. A 5,543,750-bp genome assembly was obtained. A total of 6,278 coding sequences are predicted from this assembly.
strain had a 77.2% probability of being a human pathogen. The average nucleotide identities (20) determined by comparison with the two most closely related bacterial strains (identified with BLASTn) in the NCBI database, Serratia marcescens strain AS1 (GenBank accession number CP010584) and Serratia marcescens strain UMH5 (GenBank accession number CP018917), were both ϳ94.2%; the average amino acid identities were 96.1% and 96.0%, respectively. When PATRIC (21, 22) was used for comparison with these two other S. marcescens strains (both from clinical samples), the pitcher S. marcescens strain was determined to have a unique fluorobenzoate degradation pathway and an increase in the number of genes involved in sulfur metabolism. This comparison also demonstrated that the pitcher strain lacked carbamate kinase (EC 2.7.2.2) but had two more glutamate ammonia ligase (EC 6.3.1.2) and two more glutamate synthase (NADPH) (EC 1.4.1.13) genes involved in nitrogen metabolism.
Data availability. This whole-genome shotgun project has been deposited in GenBank under accession number NZ_QPFX00000000. The raw read SRA accession number is SRX6867789. The version described in this paper is the first version. The BioProject accession number is PRJNA481376. The BioSample accession number is SAMN09666492.
